TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
-3%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$55.4B
AUM Growth
-$4.58B
(-7.6%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-3.6%
Top 10 Holdings %
Top 10 Hldgs %
30.03%
Holding
1,460
New
85
Increased
592
Reduced
634
Closed
82
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$255M |
| 2 |
SPDR Euro Stoxx 50 ETF
FEZ
|
$111M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
$92.7M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$76.3M |
| 5 |
AbbVie
ABBV
|
$64.6M |
Top Sells
| 1 |
Royal Bank of Canada
RY
|
$144M |
| 2 |
Toronto Dominion Bank
TD
|
$126M |
| 3 |
Scotiabank
BNS
|
$124M |
| 4 |
Cencora
COR
|
$96.5M |
| 5 |
Johnson & Johnson
JNJ
|
$93.6M |
Sector Composition
| 1 | Financials | 30.47% |
| 2 | Energy | 13.01% |
| 3 | Industrials | 9.7% |
| 4 | Communication Services | 8.04% |
| 5 | Technology | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLCM
1176
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $341K | ﹤0.01% |
1,470
+420
| +40% | +$97.4K |
|
1177
UDR
UDR
$13B
| $339K | ﹤0.01% |
9,955
+1,155
| +13% | +$39.3K |
|
|
ACOR
1178
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $339K | ﹤0.01% |
85
+17
| +25% | +$67.8K |
|
|
S
1179
DELISTED
Sprint Corporation
S
| $339K | ﹤0.01% |
71,528
+3,821
| +6% | +$18.1K |
|
|
CLLS
1180
Cellectis
CLLS
$269M
| $336K | ﹤0.01% |
+9,700
| New | +$336K |
|
1181
Edgewell Personal Care
EPC
$1.09B
| $333K | ﹤0.01% |
3,255
+382
| +13% | +$39.1K |
|
1182
iShares International Select Dividend ETF
IDV
$5.74B
| $332K | ﹤0.01% |
9,383
-13,750
| -59% | -$487K |
|
|
FMER
1183
DELISTED
FIRSTMERIT CORP
FMER
| $331K | ﹤0.01% |
17,350
+2,200
| +15% | +$42K |
|
1184
Flotek Industries
FTK
$336M
| $329K | ﹤0.01% |
3,717
+717
| +24% | +$63.5K |
|
|
Y
1185
DELISTED
Alleghany Corporation
Y
| $329K | ﹤0.01% |
675
+175
| +35% | +$85.3K |
|
1186
Owens & Minor
OMI
$434M
| $327K | ﹤0.01% |
+9,650
| New | +$327K |
|
|
VIRX
1187
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $327K | ﹤0.01% |
636
| – | – |
|
|
HIBB
1188
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $327K | ﹤0.01% |
6,670
+500
| +8% | +$24.5K |
|
|
SQI
1189
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $325K | ﹤0.01% |
19,200
+4,500
| +31% | +$76.2K |
|
1190
Five Below
FIVE
$8.46B
| $323K | ﹤0.01% |
9,090
-24,900
| -73% | -$885K |
|
1191
Synaptics
SYNA
$2.7B
| $323K | ﹤0.01% |
3,973
-3,018
| -43% | -$245K |
|
1192
Quanex
NX
$836M
| $322K | ﹤0.01% |
16,300
+700
| +4% | +$13.8K |
|
1193
Matsons
MATX
$3.36B
| $320K | ﹤0.01% |
7,600
+300
| +4% | +$12.6K |
|
1194
Silicon Laboratories
SLAB
$4.45B
| $320K | ﹤0.01% |
6,300
-400
| -6% | -$20.3K |
|
1195
Westamerica Bancorp
WABC
$1.26B
| $320K | ﹤0.01% |
7,400
-200
| -3% | -$8.65K |
|
|
ANSS
1196
DELISTED
Ansys
ANSS
| $319K | ﹤0.01% |
3,622
+422
| +13% | +$37.2K |
|
1197
Outfront Media
OUT
$3.05B
| $319K | ﹤0.01% |
10,818
-36,749
| -77% | -$1.08M |
|
1198
Gentex
GNTX
$6.25B
| $318K | ﹤0.01% |
17,400
+2,600
| +18% | +$47.5K |
|
|
BGG
1199
DELISTED
Briggs & Stratton Corp.
BGG
| $315K | ﹤0.01% |
15,354
-13,215
| -46% | -$271K |
|
|
BMR
1200
DELISTED
BIOMED REALTY TRUST INC
BMR
| $314K | ﹤0.01% |
+13,874
| New | +$314K |
|